There are currently 33 active clinical trials seeking participants for Glaucoma research studies. The states with the highest number of trials for Glaucoma participants are California, Texas, New York and Florida.
Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients
NCT05654493
Recruiting
The purpose of this study is to evaluate the clinical outcomes of the Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) after 1 day, 1 week,1 month, 3 months, 6 months and one year of follow-up, with the intent to evaluate the efficacy of using MP-TSCPC to treat glaucoma patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/28/2024
Locations: Mayo Clinic Florida, Jacksonville, Florida
Conditions: Glaucoma
Register for Updates
Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
NCT05523622
Recruiting
We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.
Gender:
All
Ages:
All
Trial Updated:
02/08/2024
Locations: Ross Eye Institute, Buffalo, New York
Conditions: Glaucoma
Register for Updates
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
NCT05273385
Recruiting
Glaucoma is the leading cause of irreversible blindness worldwide. Previous studies demonstrate that smaller eye drops used in the treatment of glaucoma are just as efficacious as their larger counterparts. The proposed study hopes to demonstrate the non-inferiority of using Nanodropper to lower intraoccular pressure (IOP) in glaucoma patients compared to standard of care eye drops.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/16/2023
Locations: University of California, San Francisco, San Francisco, California
Conditions: Glaucoma, Ocular Hypertension, Open Angle Glaucoma
Register for Updates
Eye Pressure Lowering Surgery
NCT01931904
Recruiting
The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
04/17/2023
Locations: OHSU, Portland, Oregon
Conditions: Glaucoma
Register for Updates
Functional and Structural Imaging for Glaucoma
NCT01957267
Recruiting
The specific aims of the clinical studies are to: Develop a directional high-resolution OCT and OCT angiography prototype to improve imaging of structure and perfusion. Validate wide-field OCT and OCT angiography parameters to improve early glaucoma detection. Simulate visual field results by combining structural and angiography OCT data. Assess abilities of above technologies and OCT-derived parameters on predicting glaucoma detection, conversion, and progression.
Gender:
All
Ages:
Between 40 years and 85 years
Trial Updated:
04/17/2023
Locations: Oregon Health & Science University, Casey Eye Institute, Portland, Oregon
Conditions: Glaucoma
Register for Updates
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
NCT04500574
Recruiting
In this research study, we will assess the safety, tolerability, comfort, and feasibility of lowering intraocular pressure using a novel Contact Lens Drug Delivery System with latanoprost. Latanoprost is a well-studied medication and has been used to treat glaucoma for decades. Currently, latanoprost is FDA-approved to be administered to patients as eye drops, but using eye drops has challenges (having to remember to take the drop, getting the drop in the eye). This clinical trial is being done... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
04/04/2023
Locations: Massachusetts Eye and Ear, Boston, Massachusetts
Conditions: Glaucoma, Ocular Hypertension
Register for Updates
P200TE and Predicate Agreement and Precision Study
NCT05624593
Recruiting
This study is a prospective comparative, randomized, single center study to assess agreement and precision of the P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
Gender:
All
Ages:
22 years and above
Trial Updated:
11/14/2022
Locations: Illinois College of Optometry, Chicago, Illinois
Conditions: Normal, Retina Disease, Glaucoma
Register for Updates
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
NCT04354545
Recruiting
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Gender:
All
Ages:
All
Trial Updated:
10/31/2022
Locations: Doheny Eye Center UCLA, Fountain Valley, California
Conditions: Glaucoma, Ocular Surface Disease
Register for Updates
Outcomes Mandate National Integration With Cannabis as Medicine
NCT03944447
Recruiting
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Gender:
All
Ages:
7 years and above
Trial Updated:
05/29/2022
Locations: OMNI Medical Services, Boca Raton, Florida +16 locations
Conditions: Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
Register for Updates